Zimmer Biomet Holdings Inc (ZBH)

[realfast95]

$ZBH Needham analyst Mike Matson maintains Zimmer Biomet Holdings with a Buy and lowers the price target from $155 to $143

$ZBH SVB Leerink analyst Danielle Antalffy maintains Zimmer Biomet Holdings with a Outperform and lowers the price target from $150 to $135

$ZBH Canaccord Genuity analyst Kyle Rose downgrades Zimmer Biomet Holdings from Buy to Hold and lowers the price target from $165 to $125

$ZBH Piper Sandler from $135.00 to $110.00

2/7 Monday's close 111.67

It's unclear with just headline analyst target's if it includes ZimVie or without ZimVie

to repeat
Zimmer Biomet shareholders of record as of the close of business on February 15, 2022 (the "Record Date"). The dividend is payable at 12:01 a.m. ET on March 1, 2022 (the "Distribution Date"). As a result of the dividend, Zimmer Biomet shareholders will receive one share of ZimVie common stock for every ten shares of Zimmer Biomet common stock they hold on the Record Date.